Breakthrough Solutions
For Effective Therapies

THERANOVIR is an innovative Health-Tech company of Research and Development of breakthrough therapies in 3 fields of closely related pathologies, Cancer, Obesity and associated metabolic diseases and Infectious Diseases by targeting a platform of signaling pathways regulated by the protein complex NRP-1/OBR, newly discovered by the CEO/CSO Dr. Zakia BELAID-SANDAL (PhD). 

Once formed and stabilized the complexe translocate to the nucleus and interacts with an transcription and DNA Damage Repair  Machineries which could explain the risk of cancer development in obesity and viral infection by HPV, HTLV1  and many other virus. 

​

Abstract 3293: Leptin induces breast cancer metastasis through a Neuropilin-1 (NRP-1)/OBR complex 

Zakia Belaid-Choucair(*) et  al .Proceedings of the 105th Annual Meeting of the American Association for Cancer Research; 2014 Apr 5-9; San Diego, CA. Philadelphia (PA): 

AACR; Cancer Res 2014;74(19 Suppl):Abstract nr 3293. doi:10.1158/1538-7445.AM2014-3293. * Dr. ZAKIA BELAID-SANDAL (PhD)  ( Widow Choucair)